These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 30413728)

  • 1. Lysosomal and network alterations in human mucopolysaccharidosis type VII iPSC-derived neurons.
    Bayó-Puxan N; Terrasso AP; Creyssels S; Simão D; Begon-Pescia C; Lavigne M; Salinas S; Bernex F; Bosch A; Kalatzis V; Levade T; Cuervo AM; Lory P; Consiglio A; Brito C; Kremer EJ
    Sci Rep; 2018 Nov; 8(1):16644. PubMed ID: 30413728
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Accumulation of abnormal amounts of glycosaminoglycans in murine mucopolysaccharidosis type VII neural progenitor cells does not alter the growth rate or efficiency of differentiation into neurons.
    Heuer GG; Skorupa AF; Prasad Alur RK; Jiang K; Wolfe JH
    Mol Cell Neurosci; 2001 Jan; 17(1):167-78. PubMed ID: 11161477
    [TBL] [Abstract][Full Text] [Related]  

  • 3. iPS-derived neural stem cells for disease modeling and evaluation of therapeutics for mucopolysaccharidosis type II.
    Hong J; Cheng YS; Yang S; Swaroop M; Xu M; Beers J; Zou J; Huang W; Marugan JJ; Cai X; Zheng W
    Exp Cell Res; 2022 Mar; 412(1):113007. PubMed ID: 34990619
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glycosaminoglycan storage in cultured neonatal murine mucopolysaccharidosis type VII neuroglial cells and correction by beta-glucuronidase gene transfer.
    Taylor RM; Wolfe JH
    J Neurochem; 1997 May; 68(5):2079-85. PubMed ID: 9109535
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical response to persistent, low-level beta-glucuronidase expression in the murine model of mucopolysaccharidosis type VII.
    Donsante A; Levy B; Vogler C; Sands MS
    J Inherit Metab Dis; 2007 Apr; 30(2):227-38. PubMed ID: 17308887
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vestronidase alfa: Recombinant human β-glucuronidase as an enzyme replacement therapy for MPS VII.
    Cadaoas J; Boyle G; Jungles S; Cullen S; Vellard M; Grubb JH; Jurecka A; Sly W; Kakkis E
    Mol Genet Metab; 2020 May; 130(1):65-76. PubMed ID: 32192868
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neural cells generated from human induced pluripotent stem cells as a model of CNS involvement in mucopolysaccharidosis type II.
    Rybová J; Ledvinová J; Sikora J; Kuchař L; Dobrovolný R
    J Inherit Metab Dis; 2018 Mar; 41(2):221-229. PubMed ID: 29168031
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Murine mucopolysaccharidosis type VII: the impact of therapies on the clinical course and pathology in a murine model of lysosomal storage disease.
    Vogler C; Sands MS; Galvin N; Levy B; Thorpe C; Barker J; Sly WS
    J Inherit Metab Dis; 1998 Aug; 21(5):575-86. PubMed ID: 9728337
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Corrective GUSB transfer to the canine mucopolysaccharidosis VII cornea using a helper-dependent canine adenovirus vector.
    Serratrice N; Cubizolle A; Ibanes S; Mestre-Francés N; Bayo-Puxan N; Creyssels S; Gennetier A; Bernex F; Verdier JM; Haskins ME; Couderc G; Malecaze F; Kalatzis V; Kremer EJ
    J Control Release; 2014 May; 181():22-31. PubMed ID: 24607662
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pathogenesis of mitral valve disease in mucopolysaccharidosis VII dogs.
    Bigg PW; Baldo G; Sleeper MM; O'Donnell PA; Bai H; Rokkam VR; Liu Y; Wu S; Giugliani R; Casal ML; Haskins ME; Ponder KP
    Mol Genet Metab; 2013 Nov; 110(3):319-28. PubMed ID: 23856419
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enzyme replacement with recombinant beta-glucuronidase in murine mucopolysaccharidosis type VII: impact of therapy during the first six weeks of life on subsequent lysosomal storage, growth, and survival.
    Vogler C; Sands MS; Levy B; Galvin N; Birkenmeier EH; Sly WS
    Pediatr Res; 1996 Jun; 39(6):1050-4. PubMed ID: 8725268
    [TBL] [Abstract][Full Text] [Related]  

  • 12. First human treatment with investigational rhGUS enzyme replacement therapy in an advanced stage MPS VII patient.
    Fox JE; Volpe L; Bullaro J; Kakkis ED; Sly WS
    Mol Genet Metab; 2015 Feb; 114(2):203-8. PubMed ID: 25468648
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transplantation of human umbilical mesenchymal stem cells cures the corneal defects of mucopolysaccharidosis VII mice.
    Coulson-Thomas VJ; Caterson B; Kao WW
    Stem Cells; 2013 Oct; 31(10):2116-26. PubMed ID: 23897660
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Abnormalities in neural progenitor cells in a dog model of lysosomal storage disease.
    Walton RM; Wolfe JH
    J Neuropathol Exp Neurol; 2007 Aug; 66(8):760-9. PubMed ID: 17882020
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Corrective GUSB transfer to the canine mucopolysaccharidosis VII brain.
    Cubizolle A; Serratrice N; Skander N; Colle MA; Ibanes S; Gennetier A; Bayo-Puxan N; Mazouni K; Mennechet F; Joussemet B; Cherel Y; Lajat Y; Vite C; Bernex F; Kalatzis V; Haskins ME; Kremer EJ
    Mol Ther; 2014 Apr; 22(4):762-73. PubMed ID: 24343103
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Decreased lysosomal storage in the adult MPS VII mouse brain in the vicinity of grafts of retroviral vector-corrected fibroblasts secreting high levels of beta-glucuronidase.
    Taylor RM; Wolfe JH
    Nat Med; 1997 Jul; 3(7):771-4. PubMed ID: 9212105
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Early onset of lysosomal storage disease in a murine model of mucopolysaccharidosis type VII: undegraded substrate accumulates in many tissues in the fetus and very young MPS VII mouse.
    Vogler C; Levy B; Galvin N; Lessard M; Soper B; Barker J
    Pediatr Dev Pathol; 2005; 8(4):453-62. PubMed ID: 16222480
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neonatal retroviral vector-mediated hepatic gene therapy reduces bone, joint, and cartilage disease in mucopolysaccharidosis VII mice and dogs.
    Mango RL; Xu L; Sands MS; Vogler C; Seiler G; Schwarz T; Haskins ME; Ponder KP
    Mol Genet Metab; 2004 May; 82(1):4-19. PubMed ID: 15110316
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Numerous transcriptional alterations in liver persist after short-term enzyme-replacement therapy in a murine model of mucopolysaccharidosis type VII.
    Woloszynek JC; Roberts M; Coleman T; Vogler C; Sly W; Semenkovich CF; Sands MS
    Biochem J; 2004 Apr; 379(Pt 2):461-9. PubMed ID: 14705966
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Disease modeling for Mucopolysaccharidosis type IIIB using patient derived induced pluripotent stem cells.
    Huang W; Cheng YS; Yang S; Swaroop M; Xu M; Huang W; Zheng W
    Exp Cell Res; 2021 Oct; 407(1):112785. PubMed ID: 34411609
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.